![Safety and pharmacodynamic dose response of short-term prednisone in healthy adult subjects: a dose ranging, randomized, placebo-controlled, crossover study | BMC Musculoskeletal Disorders | Full Text Safety and pharmacodynamic dose response of short-term prednisone in healthy adult subjects: a dose ranging, randomized, placebo-controlled, crossover study | BMC Musculoskeletal Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12891-016-1135-3/MediaObjects/12891_2016_1135_Fig1_HTML.gif)
Safety and pharmacodynamic dose response of short-term prednisone in healthy adult subjects: a dose ranging, randomized, placebo-controlled, crossover study | BMC Musculoskeletal Disorders | Full Text
![What Corticosteroid is Most Appropriate for treating Acute Exacerbations of CoPD? - Page 2 of 4 - The Hospitalist What Corticosteroid is Most Appropriate for treating Acute Exacerbations of CoPD? - Page 2 of 4 - The Hospitalist](https://www.the-hospitalist.org/wp-content/uploads/legacy/files/images/TH_2011_June_pp18_t01_LG.jpg)
What Corticosteroid is Most Appropriate for treating Acute Exacerbations of CoPD? - Page 2 of 4 - The Hospitalist
Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial | Haematologica
![Personalized Variable vs Fixed-Dose Systemic Corticosteroid Therapy in Hospitalized Patients With Acute Exacerbations of COPD - CHEST Personalized Variable vs Fixed-Dose Systemic Corticosteroid Therapy in Hospitalized Patients With Acute Exacerbations of COPD - CHEST](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6abde801-76cf-45a2-8320-e5fd19b926cd/fx1_lrg.jpg)
Personalized Variable vs Fixed-Dose Systemic Corticosteroid Therapy in Hospitalized Patients With Acute Exacerbations of COPD - CHEST
![Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes | Diabetology & Metabolic Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes | Diabetology & Metabolic](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13098-020-00583-7/MediaObjects/13098_2020_583_Fig2_HTML.png)